New Jersey · 2026-2027 Regular Session · Bill
S 4210: Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 4210 is a bill introduced in the New Jersey Senate on May 11, 2026. According to its official title, it concerns: Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder. Primary sponsor: Raj Mukherji (Democratic). Most recent recorded action (June 11, 2026): Combined with S4194 (SCS).
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Raj Mukherji | Primary sponsor | Democratic | Senate | 32 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Combined with S4194 (SCS)
- Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee